For laboratories investigating the downstream growth factor signalling pathway separately, our IGF-1 LR3 research guide provides detailed information on how IGF-1 LR3 is used to study growth factor receptor biology in controlled research settings
In this Medical Minute, Yuval Patel, MD, MHS discusses some of the most common conditions associated with fatty liver disease, including diabetes, obesity, high cholesterol, thyroid disorders and hypertension
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration
The information presented does not imply US FDA approval and should not be construed as a recommendation for use
Results depend on dosage, personal metabolism, and intake method
doi: 10.1038/sj.ejcn.1602349 123 HessSYZimmermannMBAdouPTorresaniTHurrellRF